Epalrestat
Epalrestat (ONO-2235) is a well-tolerated aldose reductase inhibitor for long-term research use. It effectively alleviates symptoms and slows the progression of diabetic neuropathy in preclinical models, particularly under conditions of good glycemic control. Its application extends to in vitro enzyme assays and in vivo studies of diabetic complications.
Product Specifications
CAS Number
82159-09-9
Product Name Alternative
ONO-2235
Field of Research
Neuroscience
Purity
>98%
Bioactivity
Aldose reductase inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 5 mg/ml) .
Smiles
CC (=C/C1=CC=CC=C1) \C=C1/SC (=S) N (CC (O) =O) C1=O
Molecular Formula
C15H13NO3S2
Molecular Weight
319.40
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2-[ (5Z) -5-[ (E) -3-phenyl-2-methylprop-2-enylidene]- 4-oxo-2-thioxo-3-thiazolidinyl]acetic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0012654-01 10 µg
Recombinant Chemokine (C-X-C motif) ligand 7 (CXCL7)
Sign In for Pricing
View Details TRV-0012654-02 50 µg
Recombinant Chemokine (C-X-C motif) ligand 7 (CXCL7)
Sign In for Pricing
View Details TRV-0012654-03 100 µg
Recombinant Chemokine (C-X-C motif) ligand 7 (CXCL7)
Sign In for Pricing
View Details TRV-0012654-04 200 µg
Recombinant Chemokine (C-X-C motif) ligand 7 (CXCL7)
Sign In for Pricing
View Details TRV-0012654-05 500 µg
Recombinant Chemokine (C-X-C motif) ligand 7 (CXCL7)
Sign In for Pricing
View Details